Regenerelle

02/13/2024

Press Release - 100 Person Exosome Trial Results Unveiled

Posted by Welcome to Age Zero, 1

02/20/2023

Join us at Derma Dubai where Dr. Heke PhD will be discussing what defines Best-in-class

02/11/2023

A cancer geneticist, Singh originally wanted to help chemotherapy patients to re-grow the hair they lose as a result of the cancer treatment. But what he found out about mitochondria could help everyone.

02/08/2023

An incredible time for our team as Dr. Michael Heke Ph.D has formally joined as AT Venture Center and subsidiaries' Chief Scientific Officer and Managing Director.

Dr. Michael Heke, Ph.D. will drive integration of exosome-based topical cosmetics, regenerative biotherapeutics medical and scientific intelligence, and as well as aspects of patient safety as Managing Director-Scientific Officer. Rochester, NY, February 8, 2023 — The Crowley Center™ for Regener...

01/18/2023

is a fascinating area of science!

The finding involves mice, but represents an important milestone in understanding what causes cells to age

01/18/2023

Researchers found that transplanting fetal stem cells into the spinal cords of people with progressive MS helped increase the neuroprotective molecules in their spinal cords and prevent further reduction of gray matter in the brain.

12/15/2022

Regenerelle's 1 Billion Exosomes hUC-MSC-EXO - For more information check out https://www.regenerellestemcells.com//product-page/1-billion-exosomes-huc-msc-exo

11/24/2022

09/06/2022

Happy Birthday to our Founder and CEO it's been an incredible year under your vision and leadership. Here is to many
more great years!!!

08/31/2022

Billions are the new millions Regenerelle

08/22/2022

See them ✨✨ sparkle! Installed, certified, and ready to use in Regenerelle's ISO 7 Clean Room.

04/10/2022

"Mesenchymal stem cells (MSCs) have been explored as promising tools for treatment of several neurological and neurodegenerative diseases. MSCs release abundant extracellular vesicles (EVs) containing a variety of biomolecules, including mRNAs, miRNAs, and proteins. We hypothesized that EVs derived from human Wharton's jelly would act as mediators of the communication between hMSCs and neurons and could protect hippocampal neurons from damage induced by Alzheimer's disease-linked amyloid beta oligomers (AβOs).

hMSC-EVs protected hippocampal neurons from damage induced by AβOs, and this was related to the transfer of enzymatically active catalase contained in EVs. Results suggest that hMSC-EVs should be further explored as a cell-free therapeutic approach to prevent neuronal damage in Alzheimer's disease.

02/27/2022

https://www.hindawi.com/journals/bmri/2015/430847/

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to collect lifesaving Wharton’s jelly derived mesenchymal stem cells (WJ-MSC). Evidences that these cells possess therapeutic properties are constantly accumulating. Collection of WJ-MSC is done at the ti...

02/19/2022

Our team is taking a enormous LEAP in 2022!

McDermott has created the Life Sciences Entrepreneurs Acceleration Program (LEAP) for entrepreneurs on a mission to improve health through innovation.

01/01/2022

Conclusion: There are numerous growth factors, cytokines, hyaluronic acid, and extracellular vesicles present in the
Wharton’s jelly formulation analyzed. The amount of these factors in Wharton’s jelly is higher compared with other
biologics and may play a role in reducing inflammation and pain and augment healing of musculoskeletal injuries.

12/29/2021

Regenerelle is leaping into 2022 with great acceleration!!! Our team has been awarded a coveted spot into the top Life Science Entrepreneurship Accelerator Program (LEAP), by number one law firm McDermott Will & Emery LLP.
https://www.mwe.com/industries/health/life-sciences-entrepreneurs-acceleration-program-leap/

McDermott has created the Life Sciences Entrepreneurs Acceleration Program (LEAP) for entrepreneurs on a mission to improve health through innovation.

12/24/2021